1Banys M, Hartkopf AD, Krawczyk N, et al. Clinical implications of the detection of circulating tumor cells in breast cancer patients[J]. Biomark Med, 2012, 6( 1 ) :109 - 118.
2Bahc M, Williams A, Dandachi N, et al. Micrometastasis: detection methods and clinical importance [ J ]. Cancer Biomark, 2010, 9(1-6) :397 -419.
3Jemal A, Siegel R, Ward E, et al. Cancer statistics 2005 [ J]. CA Cancer J Clin, 2009, 59(4) : 225 -249.
4Lin H, Balic M, Zheng S, et al. Disseminated and circulating tumor cells: Role in effective cancer management[ J ]. Crit Rev Oneol Hematol, 2011, 77(1) :1 - 11.
5Bednarz-Knoll N, Alix-Panabieres C, Pantel K. Clinical relevance and biology of circulating tumor ceils [ J ]. Breast Cancer Res, 2011, 13(6) :228.
6Saloustros E, Perraki M, Apostolaki S, et al. Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse[J]. Breast Cancer Res, 2011, 13(3) :60.
7Cabinakova M, Tesarova P. Disseminated and circulating tumour cells and their role in breast cancer [ J]. Folia Bio (Praha), 2012,58(3) :87 -97.
8Liu ZZ, Xie XD, Qu SX, et al. Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer [ J ]. Clin Exp Metastasis, 2010, 27 (4) : 251 - 259.
9Skliris GP, Hube F, Gheorghiu I, et al. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers[ J ]. Histopathology, 2008, 52(3) :355 -369.
10Rehman F, Nagi AH, Hussain M. Immunohistochemical expression and correlation of mammaglobin with the grading system of breast carcinoma[ J]. Indian J Pathol Microbiol, 2010, 53 (4) : 619 - 623.
